Feeley Kevin, CFO, reported an open-market or private sale at GeneDx Holdings Corp. involving 261.000000 shares for an estimated $27128.34. Reported holdings after the transaction were 3906.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
CHIEF FINANCIAL OFFICER
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
Reflects the acquisition of 500 shares acquired under the Company's Employee Stock Purchase Plan on October 31, 2024.
The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy ta…
6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
0 other filings
0 recent txs